Xu-Jun He
Overview
Explore the profile of Xu-Jun He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
735
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He X, Ma Y, Yu S, Jiang X, Lu Y, Tao L, et al.
BMC Cancer
. 2022 Jul;
22(1):766.
PMID: 35836142
No abstract available.
2.
Ye S, He X, Ding L, Pan Z, Tong Y, Wu M, et al.
Chem Commun (Camb)
. 2020 Sep;
56(75):11142.
PMID: 32929425
Correction for 'Cu2O template synthesis of high-performance PtCu alloy yolk-shell cube catalysts for direct methanol fuel cells' by Sheng-Hua Ye et al., Chem. Commun., 2014, 50, 12337-12340, DOI: 10.1039/C4CC04108A.
3.
Feng J, Ding L, Ye S, He X, Xu H, Tong Y, et al.
Adv Mater
. 2019 Dec;
31(51):e1904101.
PMID: 31846542
No abstract available.
4.
Wang Z, Ying Y, Li K, Zhang Y, Chen B, Zeng J, et al.
Exp Ther Med
. 2017 Oct;
14(3):2477-2484.
PMID: 28962183
An extract from a traditional Chinese herb, (trade name, Xiao-Ai-Ping) has been approved for use on the Chinese market as a cancer chemotherapeutic agent for decades. Previous studies have demonstrated...
5.
Xia Y, Jiang X, Jiang S, He X, Luo J, Liu Z, et al.
Mol Med Rep
. 2017 Sep;
16(5):6882-6889.
PMID: 28901473
Prolyl hydroxylase 3 (PHD3) is widely accepted as a tumor suppressor; however, the expression of PHD3 in various cancer types remains controversial. The present study aimed to investigate the association...
6.
Chen B, Chen D, Lyu J, Li K, Jiang M, Zeng J, et al.
Chin J Nat Med
. 2017 Mar;
14(12):922-930.
PMID: 28262119
Marsdeniae tenacissimae extract (MTE), commonly known as Xiao-Ai-Ping in China, is a traditional Chinese herb medicine capable of inhibiting proliferation and metastasis and boosting apoptosis in various cancer cells. However,...
7.
Jiang S, He X, Xia Y, Hu W, Luo J, Zhang J, et al.
Onco Targets Ther
. 2016 May;
9:2305-15.
PMID: 27143926
MicroRNA (miR)-145-5p has been reported to function as a suppressor of cancer and plays an important role in cancer invasiveness. Epithelial-mesenchymal transition (EMT) is an important process in cancer invasion...
8.
Huang D, Tao H, He X, Long M, Yu S, Xia Y, et al.
Oncotarget
. 2015 Oct;
6(38):40953-8.
PMID: 26506520
Besides CDH1, few hereditary gastric cancer predisposition genes have been previously reported. In this study, we discovered two germline ATM mutations (p.Y1203fs and p.N1223S) in a Chinese family with a...
9.
Feng J, Ding L, Ye S, He X, Xu H, Tong Y, et al.
Adv Mater
. 2015 Oct;
27(44):7051-7.
PMID: 26436879
Hybrid electrocatalysts with excellent electrocatalytic activity for hydrogen reduction are fabricated using an efficient and facile electrochemical route. The electronic and synergistic effects between Co(OH)2 and polyaniline (PANI) in the...
10.
Huang D, Wang Z, He X, Diplas B, Yang R, Killela P, et al.
Eur J Cancer
. 2015 Apr;
51(8):969-76.
PMID: 25843513
Background: Several somatic mutation hotspots were recently identified in the telomerase reverse transcriptase (TERT) promoter region in human cancers. Large scale studies of these mutations in multiple tumour types are...